This article has been reviewed according to Science X's editorial process and policies. Editors have highlighted the following attributes while ensuring the content's credibility:

fact-checked

peer-reviewed publication

reputable news agency

proofread

Mortality increased for infants under 5 with HIV receiving antiretrovirals, research finds

Mortality increased for infants, under 5s with HIV receiving antiretrovirals

More infants and children aged younger than 5 years with HIV receiving antiretroviral therapy (ART) die compared with those aged 5 years and older receiving ART, according to research published in the Dec. 1 issue of the U.S. Centers for Disease Control and Prevention Morbidity and Mortality Weekly Report.

Nickolas T. Agathis, M.D., from the CDC in Atlanta, and colleagues compared mortality and related clinical measures among younger than 1 year and children aged 1 to 4 years living with HIV and receiving ART compared to those of aged 5 to 14, 15 to 49, and 50 years and older living with HIV and receiving ART.

An average of 11,980 infants aged younger than 1 year and 105,510 children aged 1 to 4 years were receiving ART each quarter during October 2020 to September 2022; of these, 4.9 and 2.5 percent, respectively, were reported to have died annually.

The researchers found that compared with the proportions of persons aged 5 years and older receiving ART, the proportions of infants and children who died ranged from four to nine times higher in infants aged younger than 1 year and from two to five times higher in children aged 1 to 4 years.

The proportions of children aged younger than 5 years living with HIV who experienced interruptions in treatment were also higher compared with persons aged 5 years and older, while lower proportions were seen with a documented HIV viral load result or suppressed viral load.

"Prioritizing and optimizing HIV and general health services for children aged <5 years living with HIV receiving ART might help address the disproportionately poorer outcomes they experience," the authors write.

More information: Nickolas T. Agathis et al, Mortality Among Children Aged <5 Years Living with HIV Who Are Receiving Antiretroviral Treatment—U.S. President's Emergency Plan for AIDS Relief, 28 Supported Countries and Regions, October 2020–September 2022, MMWR. Morbidity and Mortality Weekly Report (2023). DOI: 10.15585/mmwr.mm7248a1

Copyright © 2023 HealthDay. All rights reserved.

Citation: Mortality increased for infants under 5 with HIV receiving antiretrovirals, research finds (2023, December 1) retrieved 27 April 2024 from https://medicalxpress.com/news/2023-12-mortality-infants-hiv-antiretrovirals.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Explore further

Research suggests severity of flu season was high for children, teens in 2022 to 2023

 shares

Feedback to editors